The Japanese pharmaceutical industry : its evolution and current challenges

Maki Umemura

1. Introduction : why didn't Japan become a global leader in pharmaceuticals? -- 2. A historical overview of Japan's pharmaceutical industry -- 3. Developing a modern industry : the antibiotics sector -- 4. What went wrong? : the anticancer drug sector -- 5. Conclusion : reconsidering Japan's business in pharmaceuticals.

MoreLess

Year of publication:	2011
Authors:	Umemura, Maki.
Publisher:	London : Routledge,
Subject:	Japan \| Pharmaindustrie \| Pharmaceutical industry

Online Resource

Check full text access |

More access options

doi.org

Check Google Scholar

In libraries world-wide (WorldCat)

In German libraries (KVK)

subito order

I need help

Extent:	1 online resource (xvii, 186 pages)
Series:	Routledge studies in the growth economies of Asia ; Volume 101
Type of publication:	Book / Working Paper
Language:	English
Notes:	Includes bibliographical references (pages [156]-180) and index.
ISBN:	978-0-203-83128-1 ; 978-1-136-82820-1 ; 978-1-136-82824-9 ; 978-1-136-82825-6 ; 978-0-415-58766-2 ; 978-1-138-48143-5
Other identifiers:	10.4324/9780203831281 [DOI]
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10014499012